GEO DataSets

(Submitter supplied) Men with clinically localized prostate cancer were treated with 0 to 9 months of neoadjuvant hormone suppression prior to prostatectomy. Keywords: microarray, hormone,

Organism:

Homo sapiens

Type:

Expression profiling by array

Platform:

GPL4768

9 Samples

Download data: GPR

(Submitter supplied) To identify molecular changes underlying the chemopreventive or tumor promoting effects of SRD5A inhibition, we profiled gene expression changes in benign prostate epithelium from patients with PCa treated with dutasteride, a dual SRD5A inhibitor. Subjects were aged 45-80 years with clinically localized PCa (T1C to T2b), Gleason score <7, and serum PSA 2.5-10 ng/dL. 81 men were randomized to immediate RP (n=25) or to dutasterdie at 0.5 mg (n=26) or 3.5 mg (n=24) orally per day for four months prior to RP. more...

Organism:

Homo sapiens

Type:

Expression profiling by array

Platform:

GPL4768

40 Samples

Download data: GPR

(Submitter supplied) The cyclin D1 oncogene encodes the regulatory subunit of a holoenzyme that phosphorylates and inactivates the Rb protein and promotes progression through G1 to S phase of the cell cycle. Several prostate cancer cell lines and a subset of primary prostate cancer samples have increased cyclin D1 protein expression. However, the relationship between cyclin D1 expression and prostate tumor progression has yet to be clearly characterized. more...

Organism:

Homo sapiens

Type:

Expression profiling by array

Platform:

GPL4768

4 Samples

Download data: GPR

(Submitter supplied) FHCRC Human Prostate PEDB cDNA Array v10 Protocol: DNA spotted onto polylysine-coated glass microscope slides

Organism:

Homo sapiens

3 Series

53 Samples

Download data